Choroidopathy of systemic lupus erythematosus

Quan Dong Nguyen, H. S. Uy, E. K. Akpek, S. L. Harper, D. N. Zacks, C. S. Foster

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Purpose: To describe the ocular and systemic manifestations associated with systemic lupus erythematosus (SLE) choroidopathy. Methods: Three new cases of choroidopathy in patients with active SLE were described. Twenty five published cases of lupus choroidopathy were summarized. Results: There have been 28 cases of lupus choroidopathy (47 involved eyes) that have been reported in the English literature since 1968, including the three current cases. Only two of the patients were male. The choroidopathy was bilateral in 19 patients (68%). All 28 patients (100%) had active systemic vascular disease at the onset of their choroidopathy; 18 (64%) had nephropathy and 10 (36%) had central nervous system (CNS) lupus vasculitis. All but one of the patients had a known diagnosis of SLE at the onset of choroidopathy. 30 of the 47 involved eyes had presenting visual acuity of 20/40 or better; 14 eyes showed improvement in visual acuity with therapy. 23 patients (82%) had resolution of their choroidopathy when their systemic disease was brought under control. Despite treatment, 4 of the 28 patients (14%) died from complications of SLE. Conclusions: Although less known than retinopathy, lupus choroidopathy may be more common than generally appreciated. It usually serves as a sensitive indicator of lupus activity. The presence of SLE choroidopathy is generally indicative of coexistent (although sometimes occult) nephropathy, CNS vasculitis, and other SLE visceral lesions. Immunomodulation of the systemic disease can lead to improvement and resolution of the systemic vasculitis as well as the choroidopathy.

Original languageEnglish (US)
Pages (from-to)288-298
Number of pages11
JournalLupus
Volume9
Issue number4
DOIs
StatePublished - Jan 1 2000

Fingerprint

Systemic Lupus Erythematosus
Visual Acuity
Eye Manifestations
Central Nervous System Lupus Vasculitis
Central Nervous System Vasculitis
Literature
Systemic Vasculitis
Immunomodulation
Vascular Diseases
Therapeutics

Keywords

  • Central nervous system (CNS)
  • Choroidopathy
  • Nephropathy
  • Retinopathy
  • Scleritis
  • Systemic lupus erythematosus (SLE)
  • Vasculitis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Nguyen, Q. D., Uy, H. S., Akpek, E. K., Harper, S. L., Zacks, D. N., & Foster, C. S. (2000). Choroidopathy of systemic lupus erythematosus. Lupus, 9(4), 288-298. https://doi.org/10.1191/096120300680199024

Choroidopathy of systemic lupus erythematosus. / Nguyen, Quan Dong; Uy, H. S.; Akpek, E. K.; Harper, S. L.; Zacks, D. N.; Foster, C. S.

In: Lupus, Vol. 9, No. 4, 01.01.2000, p. 288-298.

Research output: Contribution to journalArticle

Nguyen, QD, Uy, HS, Akpek, EK, Harper, SL, Zacks, DN & Foster, CS 2000, 'Choroidopathy of systemic lupus erythematosus', Lupus, vol. 9, no. 4, pp. 288-298. https://doi.org/10.1191/096120300680199024
Nguyen QD, Uy HS, Akpek EK, Harper SL, Zacks DN, Foster CS. Choroidopathy of systemic lupus erythematosus. Lupus. 2000 Jan 1;9(4):288-298. https://doi.org/10.1191/096120300680199024
Nguyen, Quan Dong ; Uy, H. S. ; Akpek, E. K. ; Harper, S. L. ; Zacks, D. N. ; Foster, C. S. / Choroidopathy of systemic lupus erythematosus. In: Lupus. 2000 ; Vol. 9, No. 4. pp. 288-298.
@article{34c0bba30d9e46528dad6c64f617c40c,
title = "Choroidopathy of systemic lupus erythematosus",
abstract = "Purpose: To describe the ocular and systemic manifestations associated with systemic lupus erythematosus (SLE) choroidopathy. Methods: Three new cases of choroidopathy in patients with active SLE were described. Twenty five published cases of lupus choroidopathy were summarized. Results: There have been 28 cases of lupus choroidopathy (47 involved eyes) that have been reported in the English literature since 1968, including the three current cases. Only two of the patients were male. The choroidopathy was bilateral in 19 patients (68{\%}). All 28 patients (100{\%}) had active systemic vascular disease at the onset of their choroidopathy; 18 (64{\%}) had nephropathy and 10 (36{\%}) had central nervous system (CNS) lupus vasculitis. All but one of the patients had a known diagnosis of SLE at the onset of choroidopathy. 30 of the 47 involved eyes had presenting visual acuity of 20/40 or better; 14 eyes showed improvement in visual acuity with therapy. 23 patients (82{\%}) had resolution of their choroidopathy when their systemic disease was brought under control. Despite treatment, 4 of the 28 patients (14{\%}) died from complications of SLE. Conclusions: Although less known than retinopathy, lupus choroidopathy may be more common than generally appreciated. It usually serves as a sensitive indicator of lupus activity. The presence of SLE choroidopathy is generally indicative of coexistent (although sometimes occult) nephropathy, CNS vasculitis, and other SLE visceral lesions. Immunomodulation of the systemic disease can lead to improvement and resolution of the systemic vasculitis as well as the choroidopathy.",
keywords = "Central nervous system (CNS), Choroidopathy, Nephropathy, Retinopathy, Scleritis, Systemic lupus erythematosus (SLE), Vasculitis",
author = "Nguyen, {Quan Dong} and Uy, {H. S.} and Akpek, {E. K.} and Harper, {S. L.} and Zacks, {D. N.} and Foster, {C. S.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1191/096120300680199024",
language = "English (US)",
volume = "9",
pages = "288--298",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Choroidopathy of systemic lupus erythematosus

AU - Nguyen, Quan Dong

AU - Uy, H. S.

AU - Akpek, E. K.

AU - Harper, S. L.

AU - Zacks, D. N.

AU - Foster, C. S.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Purpose: To describe the ocular and systemic manifestations associated with systemic lupus erythematosus (SLE) choroidopathy. Methods: Three new cases of choroidopathy in patients with active SLE were described. Twenty five published cases of lupus choroidopathy were summarized. Results: There have been 28 cases of lupus choroidopathy (47 involved eyes) that have been reported in the English literature since 1968, including the three current cases. Only two of the patients were male. The choroidopathy was bilateral in 19 patients (68%). All 28 patients (100%) had active systemic vascular disease at the onset of their choroidopathy; 18 (64%) had nephropathy and 10 (36%) had central nervous system (CNS) lupus vasculitis. All but one of the patients had a known diagnosis of SLE at the onset of choroidopathy. 30 of the 47 involved eyes had presenting visual acuity of 20/40 or better; 14 eyes showed improvement in visual acuity with therapy. 23 patients (82%) had resolution of their choroidopathy when their systemic disease was brought under control. Despite treatment, 4 of the 28 patients (14%) died from complications of SLE. Conclusions: Although less known than retinopathy, lupus choroidopathy may be more common than generally appreciated. It usually serves as a sensitive indicator of lupus activity. The presence of SLE choroidopathy is generally indicative of coexistent (although sometimes occult) nephropathy, CNS vasculitis, and other SLE visceral lesions. Immunomodulation of the systemic disease can lead to improvement and resolution of the systemic vasculitis as well as the choroidopathy.

AB - Purpose: To describe the ocular and systemic manifestations associated with systemic lupus erythematosus (SLE) choroidopathy. Methods: Three new cases of choroidopathy in patients with active SLE were described. Twenty five published cases of lupus choroidopathy were summarized. Results: There have been 28 cases of lupus choroidopathy (47 involved eyes) that have been reported in the English literature since 1968, including the three current cases. Only two of the patients were male. The choroidopathy was bilateral in 19 patients (68%). All 28 patients (100%) had active systemic vascular disease at the onset of their choroidopathy; 18 (64%) had nephropathy and 10 (36%) had central nervous system (CNS) lupus vasculitis. All but one of the patients had a known diagnosis of SLE at the onset of choroidopathy. 30 of the 47 involved eyes had presenting visual acuity of 20/40 or better; 14 eyes showed improvement in visual acuity with therapy. 23 patients (82%) had resolution of their choroidopathy when their systemic disease was brought under control. Despite treatment, 4 of the 28 patients (14%) died from complications of SLE. Conclusions: Although less known than retinopathy, lupus choroidopathy may be more common than generally appreciated. It usually serves as a sensitive indicator of lupus activity. The presence of SLE choroidopathy is generally indicative of coexistent (although sometimes occult) nephropathy, CNS vasculitis, and other SLE visceral lesions. Immunomodulation of the systemic disease can lead to improvement and resolution of the systemic vasculitis as well as the choroidopathy.

KW - Central nervous system (CNS)

KW - Choroidopathy

KW - Nephropathy

KW - Retinopathy

KW - Scleritis

KW - Systemic lupus erythematosus (SLE)

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=0034018338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034018338&partnerID=8YFLogxK

U2 - 10.1191/096120300680199024

DO - 10.1191/096120300680199024

M3 - Article

VL - 9

SP - 288

EP - 298

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 4

ER -